Cervical cancer prevention: Human papillomavirus testing as primary screening.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 34767263.
- Also identified by DOI 10.1002/cncr.34006.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Low- and middle-income countries carry a high burden of preventable cervical cancer cases and deaths. Because human papillomavirus DNA-based testing is increasingly becoming the preferred method of screening for cervical cancer prevention, this commentary discusses next steps and key considerations for its expansion.
Medical subject headings
- Alphapapillomavirus
- Papillomavirus Infections
- Papillomavirus Vaccines
- Uterine Cervical Neoplasms